Comparison of response to salmeterol/fluticasone combination (SFC) therapy in elderly- versus younger- onset asthma and COPD
Not Applicable
- Conditions
- Bronchial asthma, COPD
- Registration Number
- JPRN-UMIN000006291
- Lead Sponsor
- Third Department of Internal Medicine, Wakayama Medical university
- Brief Summary
The results was reported as an original article. Am J Geriatric Soc 2012;60:1587-1588
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Asthma: History of smoking. COPD: Current smokers. Common criteria: 1, Diagnosed with non-COPD / non-asthma respiratory disorders and heart diseases. 2, Poor adherence. 3, Use inhaled, oral, and injection steroids within 8 weeks before enrollment. 4, Patients have hypersensitivity to salmeterol or fluticasone propionate, or suspected patient. 5, The patients who are inappropriate considered by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asthma control questionnaire (ACQ) Spirometry exhaled nitric oxide exacerbation Asthma Control Test (ACT) COPD Assessment Test (CAT)
- Secondary Outcome Measures
Name Time Method Relevance of changes in the primary Outcomes. The following background factors at start of intervention. Age Gender Height Weight Duration of disease Smoking history Co morbidity Blood test Reversibility of airway. Adverse events, serious adverse events, side effects, number and frequency of serious side effects. The percentage of discontinued patients(%)